Faculty Bibliography

BACKGROUND CONTEXT: Frailty has been utilized in cervical deformity (CD) to characterize the influence of preop health state on postop outcomes. Frailty severity may be an important determinant for impaired recovery after CD corrective surgery. No prior studies have examined the associations between increasingly frail states and the trajectory of recovery in CD realignment. PURPOSE: Evaluate postop clinical recovery among CD patients between frailty states undergoing primary procedures STUDY DESIGN/SETTING: Retrospective review of a prospective CD database PATIENT SAMPLE: A total of 106 CD patients. OUTCOME MEASURES: Baseline (BL) to 1-Year(1Y) HRQL Instruments: NDI, mJOA, EQ5D METHODS: Patients>18yrs undergoing surgery for CD (C2-7 Cobb>10degree, coronal Cobb>10degree, cSVA>4cm or TS-CL>10degree, or CBVA>25degree) with HRQL data at BL, 3M and 1Y postop intervals were identified. Patients were stratified by the modified CD frailty index (mCD-FI, Passias et al.) scale from 0-1 (no frailty:<0.3[NF], mild/severe: >0.3[F]). Patients in NF and F groups were propensity score matched (PSM) for TS-CL to control for baseline deformity. Demographics, alignment and Ames-ISSG deformity modifiers were assessed using chi-squared and paired t-tests to compare HRQL outcomes. HRQL outcomes were normalized by dividing BL and postop (3M, 1Y) outcomes by BL for each patient. Normalized scores (y-axis) were plotted against duration of follow-up (x-axis). AUC was calculated for follow-up time intervals; total area for each follow-up interval was divided by cumulative follow-up, determining overall normalized, time-adjusted HRQL outcomes (Integrated Health State [IHS]). IHS was compared between NF and F groups.
RESULT(S): A total of 106 CD patients included (61.7yrs, 66% F, 27.7kg/m2). By frailty group: 52.8% NF, 47.2% F. After PSM for TS-CL (mean: 38.1degree), 38 patients remained in each of the NF and F groups. By surgical approach, 46.1% underwent posterior approach, 19.7% anterior, and 34.2% combined; which was not significant between the frailty groups(p>0.05). At baseline, cervical and spinopelvic radiographic parameters were not significant, except for the C7-S1 SVA (NF: -26.5mm vs F: 15.2mm, p=0.007). According to BL HRQLs, F patients displayed significantly worse NDI scores (NF: 36.8 F: 55.4; p<0.001), mJOA (NF: 14.7, F: 12.7; p=0.002), and EQ5D (NF: 0.78, F: 0.69; p<0.001). All frailty groups exhibited BL to 1Y improvement in NDI, EQ5D and NRS Neck Pain (all p<0.001). After HRQL normalization, F patients had more improvement in mJOA scores at 3M (p=0.065) as well as NDI (p=0.096) and EQ5D (p=0.016). IHS-adjusted HRQL outcomes from BL to 1Y showed a significant difference in EQ5D scores (NF: 1.02, F: 1.07, P=0.016). No significant differences were found in the IHS NDI and mJOA between frailty groups (p>0.05). F patients had more postop major complications (31.3%) compared to the NF (8.9%), p=0.004, though DJK occurrence and reoperation between the groups was not significant.
CONCLUSION(S): While all groups exhibited improved postop disability/pain scores, frail patients recovered better in overall health state. Despite frail patients having more complications, they seem to have overall better patient-reported outcomes, signifying that with frailty severity, patients have more room for improvement postop compared to baseline quality of life. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Proximal junctional failure (PJF) is a common and particularly adverse complication of adult spinal deformity (ASD) surgery. There is evidence that the rigidity of posterior spinal constructs may impact risk of PJF. PURPOSE: We hypothesized that lower mean screws per level and decreased rod stiffness would be associated with lower incidence of PJF. STUDY DESIGN/SETTING: Retrospective cohort study. PATIENT SAMPLE: Patients with ASD and 2-year minimum follow-up were included. Only patients undergoing fusion of >=5 levels, and with LIV at the sacro-pelvis were included. Patients undergoing revision surgery were excluded. In total, 420 patients were analyzed. OUTCOME MEASURES: The primary outcome variable was PJF, defined using previously published radiographic criteria (PJ angle >28degreeand PJ angle >22degree, and >=8mm/>=3mm listhesis at upper thoracic / thoracolumbar levels, respectively).
METHOD(S): The primary independent variables were the mean number of screws per level fused analyzed with a cutoff of 1.8 (determined by ROC analysis) and rod material/diameter. Multivariable logistic regression was utilized to investigate confounding factors, including age, history of osteoporosis, BMI, gender, CCI, preoperative Schwab modifiers, preoperative TPA, postoperative change in lumbar lordosis, upper instrumented vertebra, osteotomy, approach, UIV type (ie, pedicle screw vs other), and number of levels fused.
RESULT(S): Of the total patients, 78.8% were female. PJF occurred in 14.1% of patients. The mean screws per level was 1.7 (SD 0.2), and 57.6% of patients had <1.8 screws per level. PJF occurred in 19.4% vs 9.8% of patients with >=1.8 vs <1.8 screws per level, respectively (p<0.01). In multivariable analysis, patients with <1.8 screws per level exhibited lower odds of PJF (OR 0.39, p<0.01). Rod material and diameter (both p>0.2) were not significantly associated with PJF. Screw density specifically adjacent to the UIV was not related to PJF (p>0.2).
CONCLUSION(S): Among ASD patients undergoing long-segment primary fusion to the pelvis, the risk of PJF was lower among patients with <1.8 screws per level. Rod diameter and material, however, were not significantly associated with PJF. This finding may be related to construct rigidity. It is possible that residual confounding by other patient and surgeon-specific characteristics may exist. Further biomechanical and clinical studies exploring the relationship between screw density and PJK/PJF are warranted. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Hyperlordotic (>20degree) anterior interbody cages (HAI) may be utilized in anterior-posterior fusion (AP-F) in efforts to improve alignment. However, significant increase in segmental lordosis (SL) in HAI without superior articulating process resection (SAP) may result in foraminal stenosis and nerve root compression causing neurological deficits and radiculopathy. Additionally, HAI with SAP may increase SL without concomitant increase in lumbar lordosis (LL). PURPOSE: Assess whether HAI without SAP in APF causes increased neurological complications. STUDY DESIGN/SETTING: Single-center retrospective cohort study PATIENT SAMPLE: A total of 158 patients undergoing single level APF were included, of which 73 had HAI placed and 85 had SAI placed. OUTCOME MEASURES: Outcomes measures included radiographic analysis of pre- and postoperative LL and SL. Perioperative neurological complications were measured including new radiculopathy, iatrogenic motor deficit and malpositioned instrumentation or compressive hematoma causing deficit. Returns to OR within 30 or 90 days were measured including return for foraminal decompression, instrumentation revision, hematoma evacuation, and irrigation and debridement.
METHOD(S): Patients undergoing primary, single level, APF without SAP resection over a 5-year period were included. Patients were classified as HAI or SAI. Outcomes measures included perioperative neurological complications, returns to OR, pre- and postoperative LL and SL. Demographic, procedural and perioperative outcomes were compared using independent samples t-tests and chi-squared analyses as appropriate with significance set at p<0.05. Risk factors for development of neurological complications were assessed with multivariate logistic regression.
RESULT(S): A total of 158 patients (73 HAI, 85 SAI) were included. Age, gender, BMI and CCI were similar between groups. HAI without SAP resulted in significantly larger change in SL (9.84+/-5.84 vs 7.32+/-5.02 deg, p=0.001), without a significantly larger change in LL (8.16+/-1.11 vs 11.5+/-1.69 deg; p=0.641) compared with SAI. HAI without SAP increased overall incidence of neurological deficit (13.69% vs 3.53%; p=0.012), iatrogenic new cases of radiculopathy (10.95% vs 3.53%; p=0.045), and iatrogenic neurological motor deficit (13.69% vs 3.53%; p=0.012). Regression analysis demonstrated that increasing cage lordosis greater than 20degree is an independent risk factor for neurological complications (p=0.046), as is higher preop SL (p=0.022). There were no significant differences in returns to OR.
CONCLUSION(S): We caution HAI implantation without SAP resection due to increased neurological complications from iatrogenic nerve root injury without the benefit of significantly improving LL correction. Use of HAI without SAP resection in single level APF should not be standard practice due to risk of neurological complications. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: The thoracolumbar junction poses increased risk for high stress on upper lumbar discs when not adequately fused. However, controversy persists. This study evaluates outcomes of upper instrumented vertebrae (UIV) selection in the thoracic versus the upper lumbar spine when fusing to the sacrum. PURPOSE: To compare revision rates for thoracolumbar fusions to the sacrum and pelvis at 1- and 2-year follow-up, stratified by UIV selection. STUDY DESIGN/SETTING: Retrospective cohort study at a single institution. PATIENT SAMPLE: A total of 968 patients who had thoracolumbar fusion surgery between 2012-2018 with at least one year of postoperative follow-up. OUTCOME MEASURES: Reoperation rates from 1 and 2 years after revision surgery, reoperation diagnoses, body mass index (BMI), gender, Charleston Comorbidity Index (CCI), perioperative complications, ASA grade (ASA), operative time (OT), and blood loss (EBL).
METHOD(S): A retrospective review of patients undergoing revision spinal fusion with lower instrumented vertebra of S1 or pelvis between 2012-2018 at a single institution was performed. Patients with less than 1 year of follow-up after their index procedure were excluded from the analysis. Patients were categorized based on UIV into 6 groups: T9-T11, L1, L2, L3, L4, and L5. Demographic and operative data were collected and compared between the different UIV groups in each cohort using chi-squared and ANOVA tests. Revision rates at 1- and 2-year follow-up and the reasons for revision were compared between groups.
RESULT(S): There were 168 revision spinal fusions that reached 1-year follow-up, with 54 having UIV at T9-T11, 2 fusions L1 to sacrum, 26 fusions L2 to sacrum, 25 fusions L3 to sacrum, 36 fusions L4 to sacrum, 23 fusions L5 to sacrum. There was significant difference in patient age, with oldest in the L1 group (65.5+/-3.5) and youngest in the L5 group (51+/-15.4 p<0.001). There was significant difference in gender as both cases in L2 was female and L5 fusions only had 39.1% females (p = 0.006). There were no differences in BMI, CCI, and ASA. EBL (1891.6mL+/-1226.9mL p <0.001) and length of stay (7.7+/-3.0 p <0.001) was highest in the T9-11 UIV group. Operative time was highest in the L1 (464.5+/-174.7 p<0.001) UIV group. Levels added on top of prior fusion were calculated by subtracting UIV of index fusion to past UIV. Adding on 2 levels had a 1-year revision rate of 14.3% (p = 0.032), while adding on 1 level had a 0% 1-year revision rate. Adding on 4 levels had a revision rate of 12.5%, and adding on 7 levels had a 50% 1-year revision rate. At 2 years, adding on 1 level had revision rate of 25% and adding on 2 levels had a revision rate of 20% (p = 0.769). There is no statistically significant difference in perioperative complication rates between UIV groups (p = 0.114). The reoperation rate at 1 year for all levels was 9% and highest in UIV at L1 (50%, p=0.06). At 2-year follow-up, the reoperation rate for the total cohort was 32.34% with the highest revision rate for fusion from L2 to sacrum (53.85%) followed by (T9-T11 sacrum fusion 42.31%, L4 to sacrum31.71%, L3 to sacrum 30%, L5 to sacrum 25.04%, L1 to sacrum 25%, p=0.195). Grouping the UIV into lower thoracic (T9-T11), upper lumbar (L2-L3), and lower lumbar (L4-L5) showed similar revision rates at one year (p=0.697). At two years, lower thoracic group had a revision rate of 40% versus, 23.3% in the upper lumbar group (p =0.399).
CONCLUSION(S): There is no statistically significant difference in reoperation rates for revision thoracolumbar fusions to the sacrum/pelvis associated with different UIV selection. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Numerous strategies are used to minimize PJK in (ASD). The use of PPS is one such strategy. Studying this topic is difficult as there is a lack of homogeneity in the patient population being studied. PURPOSE: Investigate if PPS minimizes the risk of perioperative PJK compared to traditional open techniques. STUDY DESIGN/SETTING: Retrospective review of prospective multicenter adult spinal deformity database PATIENT SAMPLE: Inclusion criteria are age >18, and one of the following: PT>25, PI-LL>10, or SVA>5 cm. OUTCOME MEASURES: NRS leg, ODI, SF-12, EQ5D, SRS-22.
METHOD(S): A prospective database was retrospectively reviewed. Inclusion criteria are age >18, and one of the following: PT>25, PI-LL>10, or SVA>5 cm. Patients were grouped as MIS (all PPS no open component) or OPEN. Propensity matching was used to create 2 equal groups controlling for: age, BMI, Preop (PI-LL, PI, TPA), and post op (PI-LL correction and posterior levels fused). PJK was evaluated in 2 groups: Mild (PJK10) 10degree change from preop and severe (PJK20) a 20degree change, as previously reported.
RESULT(S): A total of 1,023 patients met criteria: 114 MIS and 909 OPEN. MIS were older with higher BMI. No significant difference was found between groups in preop alignment or SRS Schwab classification. OPEN had more levels fused (11.3 vs 5.5), change in PI-LL (14.9 vs 9.3) and LL (16.2 vs 9.7; all p<0.01). After matching: 77 patients in each group with no difference in demographics or levels fused (6.26 +/- 3.7 OPEN; 6.23 +/- 3.4 MIS). At 1YR NRS leg, ODI, SF-12, EQ5D, SRS-22 were equal. MIS had improved NSR Back compared to OPEN (2.6 vs 3.4; p=0.047). Alignment (PI-LL, TPA, SVA, LL, PT, PI) showed no difference preop, 6 weeks or at 1YR. PJK10 was 23.9% OPEN v 20.3% in MIS at 6 weeks and 28.6% and 19.5% at 1 YR (p>0.59). PJK20 was 2.6% in OPEN vs 3.9% in MIS at 1YR (p=1). The PJK angle was not different (4.3 v 4.2). MIS had less EBL (510 v 1574 cc; p=0.000) longer OR time (448 v 373 min; p=0.022) and more interbodies (3.4 vs 2.1; p=0.000). There was no difference in rate of revision surgery (14.3% OPEN vs 10.4%). Major complications occurred more frequently in OPEN (23.4% vs 9.1%).
CONCLUSION(S): While the use of percutaneous fixation intuitively seems protective for PJK, our study found that when controlling for radiographic deformity, deformity correction, demographics and the magnitude of surgical intervention that percutaneous fixation is equivalent to open techniques in rate of perioperative PJK. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Opioid use prior to surgery is associated with worse postop outcomes. Little is known regarding the economic impact that preop opioid use has upon patient preferred health state, quality adjusted life years (QALYs) and the cost/QALY of surgical treatment for adult spinal deformity (ASD). PURPOSE: Compare the health state preference values, QALYs, and cost/QALY for operatively treated ASD patients that used opioids vs did not use opioids prior to surgery. STUDY DESIGN/SETTING: Cost/QALY analysis of operatively treated patients identified from a prospective, multi-center ASD study. PATIENT SAMPLE: Propensity score matched (PSM) cohorts of patients that used opioids (OPIOID) vs nonusers (NON) prior to ASD surgery, at 1- and minimum 2-year follow up. OUTCOME MEASURES: Short Form-36v2 questionnaire (SF-36), SF6D derived from SF-36, hospital costs for operative treatment of ASD based on CMS DRG reimbursements, QALYs, cost/QALY for index surgery, perioperative complications, and 1- and 2-year postop opioid use.
METHOD(S): ASD patients (age>18 years) enrolled into a prospective multicenter ASD database were divided into preop opioid (OPIOID) vs nonopioid (NON) users. PSM was performed to control for confounding demographic, radiographic, and surgical variables. Preop, 1-year, and minimum 2-year postop SF6D values obtained, 1- and 2-year post QALYs were calculated using SF6D change from baseline, hospital costs at the time of index surgery were calculated using CMS DRG reimbursements adjusted for inflation to 2019 US dollars, cost/QALY evaluated at 1- and 2-years postop, perioperative complications, and 1- and 2-year postop opioid use was evaluated for OPIOID vs NON.
RESULT(S): DRG data was available for 182/262 patients meeting inclusion criteria. Following PSM, preoperative demographics, radiographic parameters, surgical treatment, and mean follow up (3.4 vs 3.3 years) were similar for OPIOID (n=68) vs NON (n=114), respectively (p>0.05). OPIOID had longer ICU (49 vs 23 hours) and hospital stay (9.7 vs 6.8 days) than NON, respectively (p<0.05). SF6D was worse for OPIOID at preop (0.521 vs 0.598), 1-year (0.613 vs 0.749), and 2-years postop (0.626 vs 0.749) than NON, respectively (p<0.05). QALYs were worse at 1- (0.567 vs 0.674) and 2-years postop (0.674 vs 0.825) for OPIOID vs NON, respectively (p<0.05). Cost of care at index surgery was greater for OPIOID ($83,363.02) vs NON ($70,281.17). Cost/QALY was higher for OPIOID at 1-year ($150,294.51vs $107,947.19) and 2-years postoperative ($69,615.78 vs $48,761.14) than NON (p<0.05). Perioperative complications were similar for OPIOID vs NON (p>0.05). Continued opioid use at 2-years postop was greater for OPIOID (52.4%) vs NON (8.7%; p>0.05).
CONCLUSION(S): Opioid use prior to ASD surgery is associated with worse patient perceived health state and greater costs to society. After controlling for patient demographics, deformity magnitude, and type of surgery, OPIOID had greater cost of care, despite similar perioperative complication rates. At 2-years postop both OPIOID and NON demonstrated cost effectiveness of index surgery (cost/QALY<$100,000), however the residual cost to society was $21,300 greater for OPIOID vs NON. Over 52% of OPIOD had continued opioid usage at 2-years postop compared to 8.7% of NON. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Neurologic complications following adult spinal deformity (ASD) are common and may play a role in the outcomes for our patients. Neurologic complications may include radiculopathy, sensory deficit or motor weakness. The impact that these specific complications have on HRQL is unknown. PURPOSE: Neurologic complications are common following ASD. Understanding their impact on Health-related quality of life (HRQL) measures is critical. STUDY DESIGN/SETTING: Retrospective cohort study of prospective ASD database. PATIENT SAMPLE: Retrospective cohort study, 733 patients. OUTCOME MEASURES: Neurologic complications, HRQL scores.
METHOD(S): ASD patients (>18yrs, scoliosis >=20degree, SVA >=5cm, PT >=25degree and/or TK >60degree). Inclusion criteria was HRQL at baseline (BL) and 1 year, and lower extremity motor score (LEMS) at BL, 6-week and 1-year ODI, SRS22r and SF36 were determined at BL and 1yr LEMS was calculated from 0-50, with 50 designated as normal motor function. Patients were divided into 4 groups: pLEMS (perfect, no deficit), dLEMS (new postop deficit that returned to normal at 1 year), iLEMS (deficit improved from abnormal baseline), and wLEMS (new postop deficit persistent at one year).
RESULT(S): A total of 733 patients were eligible, with 95 (12.96%) reporting neurologic complications (NC). Impact of any NC vs no complication at 1yr was significant for ODI (5.1), PCS (3.6) and SRSpain (0.2) at 1 year (p<0.001 all). For NC vs any other complication, there was still a decrease in ODI (3.9) and PCS (2.4) at 1 year (p<0.01). NC subtype: radiculopathy caused worse outcomes for (4.3) and SRS pain (0.3) (p<0.05), sensory deficit caused worse SRSmental (0.5) (p<0.05), but no HRQL change was detected for motor deficit at 1 year. PLEMS (456/733) had improvement in all HRQL, and these improvements were not different with or w/o NC, or non-NC. Compared to pLEMS w/o complication, dLEMS (62/733) and iLEMS (147/733) were statically similar, however wLEMS (68/733) had worse ODI (7.1), SRStotal (0.3), activity (0.3), mental (0.3), pain (0.3) (p<0.05 all).
CONCLUSION(S): Neurologic complications that occur following ASD have a significant effect on HRQLs. The magnitude of effect is driven by radiculopathy and by lower extremity motor score. LEMS scores that remain normal, return back to normal or improve have similar outcomes, while patients that have continued weakness remain statistically worse at 1 year. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Prior studies have demonstrated potential benefits of adult spinal deformity (ASD) surgery, but less outcomes data exist for operative ASD patients with severe scoliotic curves (thoracic [TH] curve >=75degree, thoracolumbar [TL] curve >=50degree, or lumbar [LL] curve >=50degree). Also, the surgical complication profile is less clear for this subset of patients with severe scoliotic deformity and warrants focused investigation. PURPOSE: The objective of the current study was to assess treatment outcomes and complication rates associated with ASD surgery in patients with severe scoliosis. STUDY DESIGN/SETTING: Retrospective review of a prospectively collected multicenter consecutive case registry PATIENT SAMPLE: Enrollment required: age >=18 yrs, scoliosis >=20degree, sagittal vertical axis (SVA) >=5cm, pelvic tilt >=25degree, and/or thoracic kyphosis >=60degree. OUTCOME MEASURES: Standard coronal and sagittal spinopelvic deformity measurements and health-related quality of life (HRQL) outcomes, which included Oswestry Disability Index (ODI), Short Form-36 (SF-36) scores, and Scoliosis Research Society-22 (SRS-22) scores.
METHOD(S): Using a prospective multicenter database, we identified surgically treated ASD patients with severe scoliosis (TH Cobb >=75degree or TL/LL Cobb >=50degree) and minimum 2-yr follow-up. Demographic data, surgical characteristics, radiographic alignment measurements, HRQL outcomes and associated complications were analyzed.
RESULT(S): Of 178 patients, 146 (82%, mean age 54 yrs, 92% women, 88 TL, 50 LL, 8 TH) had minimum 2-yr follow-up (mean=3.1 yrs). Almost 30% had prior spine fusion, 6% were active or past smokers, 16% had osteoporosis and 77% had at least 1 comorbidity. Surgical details included: posterior-only (58%) or anterior-posterior approach (42%), SPO (65%), 3CO (14%), TLIF (23%), ALIF (37%), sacropelvic fixation (76%), upper thoracic UIV (64%) and mean posterior fusion length of 13.2 levels. Postoperative coronal alignment improved significantly for all patients (global coronal alignment 3.8 to 2.8 cm, p< 0.001; TH Cobb 38degree to 24degree, p<0.001; TL Cobb 61degree to 30degree, p<0.001; LL Cobb 50degree to 24degree, p<0.001; Fractional Cobb 20degree to 7degree, p<0.001). Overall sagittal alignment also improved significantly (p<0.05), most notably for severe lumbar curves (C7-S1 SVA 6.7 to 2.5 cm, p<0.001; PI-LL 18degreeto 3degree, p<0.001). Overall HRQL improved significantly, including ODI (39 to 26, p<0.001), SF-36 PCS (35 to 41, p<0.001) and SRS-22r (2.9 to 3.8, p<0.001). A total of 191 complications were reported (92 minor/99 major), and 94 (64%) patients had at least one complication. The most common complications included dural tear (12%), pleural effusion (12%), rod fracture (11%), radiculopathy (8%) and proximal junctional kyphosis (7%). 34 reoperations were performed in 27 (18%) patients, with most common indications of rod fracture/pseudarthrosis (8), deep wound infection (6) and neurological deficit (5).
CONCLUSION(S): Surgery for severe adult scoliosis is associated with significant improvement in radiographic alignment and HRQL measures. Although associated complication rates are high, these appear to be comparable to reports of less severe scoliosis. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Revision surgery is often necessary for adult spinal deformity (ASD) patients. Satisfaction with management is an important component of HRQOL. PURPOSE: We hypothesized that patients who underwent multiple revision surgeries following adult spinal deformity correction would exhibit lower satisfaction scores. STUDY DESIGN/SETTING: Retrospective cohort study of a prospectively collected multicenter database of ASD patients. PATIENT SAMPLE: A total of 668 patients undergoing ASD surgery and eligible for minimum 2-year follow-up were included. OUTCOME MEASURES: SRS-22r satisfaction score.
METHOD(S): Visits were stratified by occurrence prior to the index surgery (period 0), after the index surgery only (period 1) (ie, never underwent revision or had not yet undergone revision), after first revision only (period 2), and after second revision only (period 3). Patients were further stratified by prior spine surgery before their index surgery. SRS-22r satisfaction scores were evaluated at all periods using multiple linear regression adjusting for age, gender, and CCI.
RESULT(S): In total, 46.6% had prior spine surgery before their index surgery. The overall revision rate was 21.3%. among patients with no spine surgery prior to the index surgery, satisfaction increased from period 0 to 1 (2.8 to 4.3, p<0.0001), decreased after one revision from period 1 to 2 (4.3 to 3.9, p=0.0004), and decreased after a second revision from period 2 to 3 (3.9 to 3.3, p=0.0437). Among patients with spine surgery prior to the index procedure, satisfaction increased from period 0 to 1 (2.8 to 4.2, p<0.0001), and decreased from period 1 to 2 (4.2 to 3.8, p=0.0011). No differences in follow-up time from last surgery were observed between visits in periods 1, 2, and 3 (all p>0.3). among patients with multiple revisions, 40% experienced rod fracture, 40% PJK, and 33% pseudarthrosis.
CONCLUSION(S): ASD patients exhibit decreased satisfaction with subsequent revision. Among patients undergoing primary surgery in our database, this effect is additive for multiple revisions. These results have important implications for surgeons, patients, insurers, hospital administrators, and policymakers. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT/BACKGROUND:Considerable debate exists regarding the optimal surgical approach for adult spinal deformity (ASD). It remains unclear which approach, posterior-only or combined anterior-posterior (AP), is more cost-effective. Our goal is to determine the 2-year cost per quality-adjusted life year (QALY) for each approach. PURPOSE/OBJECTIVE:To compare the 2-year cost-effectiveness of surgical treatment for ASD between the posterior-only approach and combined AP approach. STUDY DESIGN/METHODS:Retrospective economic analysis of a prospective, multicenter database PATIENT SAMPLE: From a prospective, multicenter surgical database of ASD, patients undergoing 5 or more level fusions through a posterior-only or AP approach were identified and compared. METHODS:QALYs gained were determined using baseline, 1-year, and 2-year post-operative Short Form 6D. Cost was calculated from actual, direct hospital costs including any subsequent readmission or revision. Cost-effectiveness was determined using cost/QALY gained. RESULTS:The AP approach showed significantly higher index cost than the posterior-only approach ($84,329 vs $64,281). This margin decreased at 2-year follow-up with total costs of $89,824 and $73,904, respectively. QALYs gained at two years were similar with 0.21 and 0.17 in the posterior-only and the AP approaches, respectively. The cost/QALY at two years after surgery was significantly higher in the AP approach ($525,080) than in the posterior-only approach ($351,086). CONCLUSIONS:We assessed 2-year cost-effectiveness for the surgical treatment through posterior-only and AP approaches. The posterior-only approach is less expensive both for the index surgery and at 2-year follow-up. The QALY gained at 2-years was similar between the two approaches. Thus, posterior-only approach was more cost-effective than the AP approach under our study parameters. However, both approaches were not cost-effective at 2-year follow-up.